About
Teva Pharmaceuticals' RISE Challenge is a global open innovation platform launched by Teva Pharmaceutical Industries Ltd. to connect startups and technology companies with Teva's business units. The initiative aims to co-create solutions for challenges faced by the pharmaceutical industry across R&D, manufacturing and supply chain, and commercial operations, driving patient impact and business transformation as part of Teva's "Pivot to Growth" strategy. Teva plans to invest tens of millions of dollars in adopting innovative solutions and offers selected startups fully funded pilots, mentorship, and the opportunity to scale their solutions within Teva's global ecosystem. The program is run from Israel and seeks to harness global talent and disruptive technologies.
Portfolio
Investment activity
1 portfolio exit on record.
Portfolio by sector
Q&A
- What is Teva Pharmaceuticals' RISE Challenge's primary investment focus?
- Teva Pharmaceuticals' RISE Challenge primarily focuses on the Health Tech & Life Sciences sector, with all its recorded investments and exits falling within this area.
- Can you name a notable portfolio company for Teva Pharmaceuticals' RISE Challenge?
- A notable portfolio company for Teva Pharmaceuticals' RISE Challenge is VBL Therapeutics, which operates in the B2B business model and focuses on targeted therapies for immune-inflammatory diseases.
- Has Teva Pharmaceuticals' RISE Challenge had any exits?
- Yes, Teva Pharmaceuticals' RISE Challenge had an exit in October 2014 when VBL Therapeutics went public on NASDAQ with a valuation of $120M, having raised $40M in capital.
- When was Teva Pharmaceuticals' RISE Challenge founded?
- Teva Pharmaceuticals' RISE Challenge was created in May 2019.
- What is the geographic focus of Teva Pharmaceuticals' RISE Challenge?
- Teva Pharmaceuticals' RISE Challenge is headquartered in Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2025-11 |
|---|